No abstract available
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Anticoagulants / adverse effects*
-
Antidotes / therapeutic use*
-
Dabigatran / adverse effects
-
Dabigatran / antagonists & inhibitors
-
Female
-
Hemorrhage* / chemically induced
-
Hemorrhage* / drug therapy
-
Hemorrhage* / prevention & control
-
Humans
-
Male
-
Pyrazoles / adverse effects
-
Pyrazoles / antagonists & inhibitors
-
Pyridines / adverse effects
-
Pyridines / antagonists & inhibitors
-
Pyridones / adverse effects
-
Pyridones / antagonists & inhibitors
-
Risk
-
Rivaroxaban / adverse effects
-
Rivaroxaban / antagonists & inhibitors
-
Thiazoles / adverse effects
-
Thiazoles / antagonists & inhibitors
Substances
-
Antibodies, Monoclonal, Humanized
-
Anticoagulants
-
Antidotes
-
Pyrazoles
-
Pyridines
-
Pyridones
-
Thiazoles
-
apixaban
-
idarucizumab
-
Rivaroxaban
-
Dabigatran
-
edoxaban